ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 10 | April 12, 1974

Download PDF Visit The Full Archive

Related Articles

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years.

October 31, 2008